Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$4.6 - $7.64 $90,620 - $150,508
-19,700 Reduced 34.02%
38,200 $197,000
Q1 2023

Aug 02, 2023

BUY
$2.79 - $6.27 $54,963 - $123,518
19,700 Added 51.57%
57,900 $305,000
Q1 2023

Apr 27, 2023

BUY
$2.79 - $6.27 $117,180 - $263,340
42,000 Added 264.15%
57,900 $305,000
Q3 2022

Oct 27, 2022

BUY
$4.09 - $6.5 $65,031 - $103,350
15,900 New
15,900 $65,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.